A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 33, Issue 5, 2009, Pages 895-898

  Kishi, Taro ^a   Ikeda, Masashi ^a,j   Kitajima, Tsuyoshi ^a   Yamanouchi, Yoshio ^a   Kinoshita, Yoko ^a   Kawashima, Kunihiro ^a   Okochi, Tomo ^a   Tsunoka, Tomoko ^a   Okumura, Takenori ^a   Inada, Toshiya ^b,c   Ujike, Hiroshi ^b,d   Yamada, Mitsuhiko ^b,e   Uchimura, Naohisa ^b,f   Sora, Ichiro ^b,g   Iyo, Masaomi ^b,h   Ozaki, Norio ^b,i   Iwata, Nakao ^a,b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Japanese Genetics Initiative for Drug Abuse ^*  (Japan)

^c SEIWA HOSPITAL   (Japan)

^d OKAYAMA UNIVERSITY   (Japan)

^e NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^f KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j CARDIFF UNIVERSITY   (United Kingdom)

more..

Author keywords

Estrogen receptor alpha gene (ESR1); Functional SNP; Methamphetamine induced psychosis

Indexed keywords

ESTROGEN RECEPTOR ALPHA; MESSENGER RNA; METHAMPHETAMINE;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; PARANOID SCHIZOPHRENIA; PATHOGENESIS; PREFRONTAL CORTEX; PSYCHOSIS; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYMPTOM;

ADULT; AMPHETAMINE-RELATED DISORDERS; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE FREQUENCY; HUMANS; MALE; METHAMPHETAMINE; MIDDLE AGED; POLYMORPHISM, GENETIC; PSYCHOSES, SUBSTANCE-INDUCED;

EID: 67649170455     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2009.04.008     Document Type: Article

References (31)

1. Albagha O.M., and Ralston S.H. Genetic determinants of susceptibility to osteoporosis. Endocrinol Metab Clin N Am 32 (2003) 65-81 (vi)
2. Albagha O.M., Pettersson U., Stewart A., McGuigan F.E., MacDonald H.M., Reid D.M., et al. Association of oestrogen receptor alpha gene polymorphisms with postmenopausal bone loss, bone mass, and quantitative ultrasound properties of bone. J Med Genet 42 (2005) 240-246
3. Aoki K., Meng G., Suzuki K., Takashi T., Kameoka Y., Nakahara K., et al. RP58 associates with condensed chromatin and mediates a sequence-specific transcriptional repression. J Biol Chem 273 (1998) 26698-26704
4. Brecht M.L., O'Brien A., von Mayrhauser C., and Anglin M.D. Methamphetamine use behaviors and gender differences. Addict Behav 29 (2004) 89-106
5. Chakravarti A. Population genetics-making sense out of sequence. Nat Genet 21 (1999) 56-60
6. Disshon K.A., Boja J.W., and Dluzen D.E. Inhibition of striatal dopamine transporter activity by 17beta-estradiol. Eur J Pharmacol 345 (1998) 207-211
7. Dluzen D.E., and McDermott J.L. Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity. Ann NY Acad Sci 965 (2002) 136-156
8. Dluzen D.E., and Liu B. Gender differences in methamphetamine use and responses: a review. Gend Med 5 (2008) 24-35
9. Ferrari S.L., and Rizzoli R. Gene variants for osteoporosis and their pleiotropic effects in aging. Mol Aspects Med 26 (2005) 145-167
10. Fox C.S., Yang Q., Cupples L.A., Guo C.Y., Atwood L.D., Murabito J.M., et al. Sex-specific association between estrogen receptor-alpha gene variation and measures of adiposity: the Framingham Heart Study. J Clin Endocrinol Metab 90 (2005) 6257-6262
11. Fuks F., Burgers W.A., Godin N., Kasai M., and Kouzarides T. Dnmt3a binds deacetylases and is recruited by a sequence-specific repressor to silence transcription. EMBO J 20 (2001) 2536-2544
12. Gajjar T.M., Anderson L.I., and Dluzen D.E. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm 110 (2003) 1215-1224
13. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshita Y., et al. Association of AKT1 with schizophrenia confirmed in a Japanese population. Biol Psychiatry 56 (2004) 698-700
14. Ikeda M., Iwata N., Suzuki T., Kitajima T., Yamanouchi Y., Kinoshiya Y., et al. Positive association of AKT1 haplotype to Japanese methamphetamine use disorder. Int J Neuropsychopharmacol 9 (2006) 77-81
15. Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., et al. Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population. Ann NY Acad Sci 1139 (2008) 70-82
16. Kulkarni J., de Castella A., Fitzgerald P.B., Gurvich C.T., Bailey M., Bartholomeusz C., et al. Estrogen in severe mental illness: a potential new treatment approach. Arch Gen Psychiatry 65 (2008) 955-960
17. Laviolette S.R. Dopamine modulation of emotional processing in cortical and subcortical neural circuits: evidence for a final common pathway in schizophrenia?. Schizophr Bull 33 (2007) 971-981
18. Lehtimaki T., Kunnas T.A., Mattila K.M., Perola M., Penttila A., Koivula T., et al. Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med 80 (2002) 176-180
19. Liu B., and Dluzen D.E. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice. Neuroendocrinology 83 (2006) 295-302
20. Maruyama H., Toji H., Harrington C.R., Sasaki K., Izumi Y., Ohnuma T., et al. Lack of an association of estrogen receptor alpha gene polymorphisms and transcriptional activity with Alzheimer disease. Arch Neurol 57 (2000) 236-240
21. Mattila K.M., Axelman K., Rinne J.O., Blomberg M., Lehtimaki T., Laippala P., et al. Interaction between estrogen receptor 1 and the epsilon4 allele of apolipoprotein E increases the risk of familial Alzheimer's disease in women. Neurosci Lett 282 (2000) 45-48
22. Munzar P., Tanda G., Justinova Z., and Goldberg S.R. Histamine h3 receptor antagonists potentiate methamphetamine self-administration and methamphetamine-induced accumbal dopamine release. Neuropsychopharmacology 29 (2004) 705-717
23. Ohtani H., Nomoto M., and Douchi T. Chronic estrogen treatment replaces striatal dopaminergic function in ovariectomized rats. Brain Res 900 (2001) 163-168
24. Russell K., Dryden D.M., Liang Y., Friesen C., O'Gorman K., Durec T., et al. Risk factors for methamphetamine use in youth: a systematic review. BMC Pediatr 8 (2008) 48
25. Sato M., Numachi Y., and Hamamura T. Relapse of paranoid psychotic state in methamphetamine model of schizophrenia. Schizophr Bull 18 (1992) 115-122
26. Shearman A.M., Cooper J.A., Kotwinski P.J., Humphries S.E., Mendelsohn M.E., Housman D.E., et al. Estrogen receptor alpha gene variation and the risk of stroke. Stroke 36 (2005) 2281-2282
27. van Duijnhoven F.J., Bezemer I.D., Peeters P.H., Roest M., Uitterlinden A.G., Grobbee D.E., et al. Polymorphisms in the estrogen receptor alpha gene and mammographic density. Cancer Epidemiol Biomark Prev 14 (2005) 2655-2660
28. Vocci F.J., Acri J., and Elkashef A. Medication development for addictive disorders: the state of the science. Am J Psychiatry 162 (2005) 1432-1440
29. Weickert C.S., Miranda-Angulo A.L., Wong J., Perlman W.R., Ward S.E., Radhakrishna V., et al. Variants in the estrogen receptor alpha gene and its mRNA contribute to risk for schizophrenia. Hum Mol Genet 17 (2008) 2293-2309
30. Wittke-Thompson J.K., Pluzhnikov A., and Cox N.J. Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 76 (2005) 967-986
31. Yaffe K., Lui L.Y., Grady D., Stone K., and Morin P. Estrogen receptor 1 polymorphisms and risk of cognitive impairment in older women. Biol Psychiatry 51 (2002) 677-682